"Dr. Petersen has practiced medicine for over twenty years in Tucson. She has served as principal investigator on dozens of clinical trials over the past several years in many different areas of medicine. She believes that in her private practice she can help one person at a time, while her efforts in research can help thousands of people worldwide."

During the past decade, Noble Clinical Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 12 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 12 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Noble Clinical Research" #1 sponsor was "Pfizer" with 5 trials, followed by "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored, "Centrexion Therapeutics" with 2 trials sponsored, "Cephalon" with 2 trials sponsored and "CyMedica Orthopedics, Inc" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Noble Clinical Research" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "IQVIA Inc." with 1 trials as a collaborator and "OSTAtistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Noble Clinical Research" are "Knee Osteoarthritis" (3 trials), "Osteoarthritis, Hip" (3 trials), "Influenza, Human" (2 trials), "Insomnia Disorder" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Noble Clinical Research" in a lesser frequency.

Most popular intervention types in "Noble Clinical Research" are "Drug" (21 trials), "Biological" (6 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "CNTX-4975-05" (2 trials), "Tolterodine Tartrate ER" (2 trials), "Aprocitentan 10 mg" (1 trials) and "Aprocitentan 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Noble Clinical Research" are 24 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Noble Clinical Research". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Noble Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Noble Clinical Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".